作为具有抗炎作用的高度选择性的BuChE抑制剂的卡瓦克罗尔/蒂摩尔衍生物:发现和生物评估
Yuan-Lin Zhang1, Hao-Yan Yang1, Jie Gou1
1Shanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, China; College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Taiyuan, Shanxi 030619, China.
新的卡瓦克罗尔/蒂摩尔衍生物被合成用于治疗阿尔茨海默病 (AD). 化合物SXF3可以选择性地抑制乙基胆酶 (BuChE) 和减少炎症,改善AD小鼠模型中的记忆.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是认知能力下降.
- 目前的治疗方法可以缓解症状,但不能阻止疾病的进展.
- 需要针对关键病理途径的多功能药物,例如胆酶抑制和神经炎症.
研究的目的:
- 设计,合成和评估新型卡尔瓦克罗尔/蒂摩尔衍生物作为多功能抗老年症药物.
- 调查对乙胆酶 (AChE) 和丁胆酶 (BuChE) 的抑制潜力.
- 在AD小鼠模型中评估抗炎作用和体内疗效.
主要方法:
- 合成了9种新型的卡瓦克罗尔/蒂摩尔衍生物,其中包含了碳酸盐基.
- 在体外酶抑制试验测定ACHE和BuChE.
- 在体外使用脂聚糖 (LPS) 诱导的BV2微质细胞进行抗炎试验.
- 在斯科波拉胺诱导的AD小鼠模型中的体内评估.
主要成果:
- 与原始化合物相比,衍生品显示出优异的BuChE抑制 (IC50:0.059.62μM) 和抗炎活性.
- 化合物SXF3表现出强大的BuChE抑制 (IC50:0.040.05μM) 具有高选择性 (SI>2000) 和显著降低插白素-1β (IL1β).
- 在体内,SXF3通过抑制BuChE改善了记忆力,并增加了海马的乙胆水平,同时还降低了IL1β水平.
结论:
- 新型卡尔瓦克罗尔/蒂摩尔衍生物,特别是SXF3,显示出作为多功能抗阿兹海默症药物的巨大潜力.
- 选择性BuChE抑制和SXF3的抗炎性质是其治疗效果的关键.
- SXF3需要对阿尔茨海默病的治疗进行进一步的研究.
更多相关视频
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
08:56Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinesterases: Distribution and Function
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
